High-dose exposure to dimethoate in vivo increased pancreas mass (219) and reduced the number of insulin granules within β-cells (218), which could contribute to the hypoinsulinemia observed in vivo (218, 219). This evidence concerns the gene INS and Hypoinsulinemia.